Epcoritamab shows promising results in treating relapsed follicular lymphoma, with FDA priority review for a groundbreaking ...

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

The promising results, along with a separate FDA decision, could signal a major expansion of the use of the two companies' ...

Illustrative image **media[706411]** Boehringer image library This press release is not intended for UK media.  HERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 75% ...

Treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy are under review.

Net loss per share (GAAP) was $0.62, but remained negative as the company continues to invest heavily in research and development. The pivotal Phase 2 trial for Danon disease was placed on clinical ...

The Trump administration’s move to reduce requirements has puzzled some legal experts while drawing applause from oil states.

According to a statement, the DGP began by reiterating his 10 key priorities for the force, noting that their effective achievement depends on three core pillars — technology, training, and ...

The Quantum Frederick data center campus is one of six projects selected as part of a pilot program to expedite Maryland’s permitting review process, the office of Gov. Wes Moore announced on Tuesday.

The initiative aims to promote awareness, early intervention, and campus-wide well-being programmes, ensuring that emotional ...

The Trump administration on Friday ordered a comprehensive review of Harvard University's federally funded research programs, and threatened to take title to or grant licenses from the school's ...

In an era where legacy structures can no longer keep pace with rising costs, workforce disruption, and rapidly evolving technologies, healthcare leaders are reimagining the very core of how their ...